A-003

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameA-003
Drug Alias Namesecond generation secretory phospholipase A2 inhibitor (Anthera)second generation sPLA2 inhibitor (Anthera)LY-433771A-003
ClassificationSmall molecules
Mechanisms of ActionPhospholipases A2 inhibitors
TargetsPhospholipases A2
Therapy Area/IndicationsCardiovascular Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAnthera Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAnthera Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsCardiovascular Diseases

Other Information

ATC CodeN/A
Related LinksN/A